1. Introduction {#s0005}
===============

Mitochondria are the powerhouses of the cell, generating the greatest amount of chemical energy in the form of ATP during cellular respiration. During respiration electrons from reduced nicotinamide adenine dinucleotide (NADH) and reduced flavin adenine dinucleotide (FADH~2~) are transferred via the electron transport chain (ETC) to molecular oxygen (O~2~). Electron flow through the ETC is coupled with the generation of an electrochemical proton gradient across the inner mitochondrial membrane that in turn yields ATP, a process known as oxidative phosphorylation (OxPhos) \[[@bb0005]\].

The ETC has four transmembrane protein complexes: complex I (CI; NADH-ubiquinone oxidoreductase), complex II (CII; succinate-ubiquinone reductase), complex III (CIII; cytochrome *bc*~1~ complex) and complex IV (CIV; cytochrome *c* oxidase). In addition to the transmembrane complexes, two mobile carriers participate in the OxPhos process: lipophilic ubiquinone (Q) and hydrophilic cytochrome *c* (C*c*), which transfer electrons from CI/CII to CIII and from CIII to CIV, respectively. The electrochemical proton gradient generated by the ETC complexes (except CII which does not pump H^+^) drives the synthesis of ATP through complex V (CV; ATP synthase). Beyond the ETC components abovementioned, several mitochondrial enzymes---namely, electron-transferring flavoprotein Q oxidoreductase, dihydroorotate dehydrogenase or glycerol-3-phosphate dehydrogenase---may act as auxiliary elements of the respiratory chain \[[@bb0010]\].

The organization and dynamics of protein components within the ETC is currently a matter of debate. Three different models have been proposed to explain their organization ([Fig. 1](#f0005){ref-type="fig"}). On one hand, the *fluid* model states that the membrane components diffuse freely and independently \[[@bb0015]\] ([Fig. 1](#f0005){ref-type="fig"}A, *right* panel). While on the other hand, the *solid* model proposes that respiratory complexes are stably associated forming supercomplexes, thus facilitating the flow of electrons \[[@bb0020],[@bb0025]\] ([Fig. 1](#f0005){ref-type="fig"}A, *left* panel). However, the idea that these two scenarios are not exclusive gave rise to the *plasticity* model; this model consists of a balanced distribution between free respiratory complexes and supercomplexes, adapting the efficiency of the ETC by means of partitioned Q and C*c* pools \[[@bb0030]\] ([Fig. 1](#f0005){ref-type="fig"}B).Fig. 1Schematic representation of the organization of respiratory complexes. A) *Solid* (*left*) and *fluid* (*right*) models. B) *Plasticity* model. All supercomplexes described in the literature are displayed. The stoichiometry of each respiratory complex is not represented. CI is in tan, CII in orange, CIII in green, CIV in purple, CV in pink, C*c* in red and ubiquinone as Q.Fig. 1

Supercomplex formation occurs in mammals, plants, yeast and some bacteria \[[@bb0035], [@bb0040], [@bb0045]\]. Among these supercomplexes, one stands out; the respirasome, which contains CI, CIII and CIV and is capable of NADH:O~2~ oxidoreduction *in vitro* \[[@bb0050]\]. The degree of association and the stoichiometries of respiratory complexes in supercomplexes depend on cell type, tissue-specific isoforms and cellular conditions \[[@bb0055], [@bb0060], [@bb0065], [@bb0070]\]. The mitochondrial intermembrane lipid content also affects supercomplex assembly \[[@bb0075], [@bb0080], [@bb0085], [@bb0090]\].

The diverse composition and stoichiometry of supercomplexes has been evidenced by blue native polyacrylamide gel electrophoresis (BN-PAGE), cryo-electron tomography and single-particle electron microscopy studies of mitochondrial fractions solubilized with mild detergents. [Fig. 1](#f0005){ref-type="fig"}B represents the different supercomplexes described in the literature. In brief, CI mainly interacts with CIII and CIV to form the respirasome (CI + CIII~2~ + CIV~1--4~) \[[@bb0050],[@bb0095], [@bb0100], [@bb0105], [@bb0110], [@bb0115], [@bb0120], [@bb0125], [@bb0130]\]. Alternatively, CIII binds to CI (CI + CIII~2~) or CIV as a monomer (CIII~2~ + CIV~1--2~) \[[@bb0035],[@bb0110],[@bb0115],[@bb0125],[@bb0135],[@bb0140]\]. Generally speaking, CV assembles oligomers and CII acts as a stand-alone complex. However, their associations with complexes I, III, and IV have also been described \[[@bb0125],[@bb0135]\].

2. Key Elements for Respiratory Supercomplex Assembly {#s0010}
=====================================================

The mechanisms which regulate the assembly of mitochondrial supercomplexes remain unsolved. However, several biomolecules have been recently described to regulate/facilitate the formation of certain supercomplexes.

As mentioned above, phospholipids mediate protein-protein interactions within the inner mitochondrial membrane. Cardiolipin---an anionic phospholipid found primarily in the inner mitochondrial membrane---represents 20% of all membrane lipids \[[@bb0145]\]. Lack of cardiolipin has been linked with metabolic disorders, such as Barth\'s Syndrome, and affects the stability of supercomplexes and the activity of CIV \[[@bb0150]\]. Phosphatidylethanolamine is a cationic phospholipid present in all cellular membranes which when depleted favours the formation of large supercomplexes \[[@bb0085]\]. Therefore, the distribution of phospholipids may play an important role in the reorganization of respiratory complexes into supercomplexes.

Several proteins have been postulated to function as chaperones or assembly factors for supercomplexes. For instance, the depletion of 28 different NADH:ubiquinone oxidoreductase supernumerary subunits (NDUF) out of 30, which are necessary for CI assembly and stability, has also been described to reduce supercomplexes containing CI + CIII~2~ and CI + CIII~2~ + CIV~1~ in human cells \[[@bb0155]\]. Although the trans-membrane NDUFA4 subunit has initially been defined as a component of CI, new reports suggest that it belongs to CIV \[[@bb0160],[@bb0165]\]. Interestingly enough, NDUFA4 has recently been postulated as a factor required for assembly of supercomplexes in growing cells and cancer tissues \[[@bb0170]\]. The MJC/DnaJC15 protein, a mitochondrial repressor of the ETC that interacts with CI, has been described as a regulator of supercomplex formation \[[@bb0175]\].

Recently, the CIV subunit COX7A2L (also known as SCAFI) has been proposed as a CIII binding protein which stabilizes the CIII~2~ + CIV~1~ supercomplex, independently of respirasome formation \[[@bb0180],[@bb0185]\]. In yeast, two respiratory complex factors (Rcf1 and Rcf2), members of the conserved hypoxia induced gene 1 (Hig1) protein family, regulate the formation and stabilization of the CIII~2~ + CIV~1--2~ supercomplex \[[@bb0190], [@bb0195], [@bb0200]\]. Rcf1 has two eukaryotic orthologues, namely HIG1 hypoxia inducible domain family 1A and 2A (HIGD1A and HIGD2A, respectively). Indeed, HIGD2A knockdown causes depletion of the CIII~2~ + CIV~1~ supercomplex \[[@bb0205]\]. Further, the ADP/ATP carrier protein has been reported to exist in association with CIII~2~ + CIV~2~ and mediates such supercomplex assembly in yeast \[[@bb0210]\]. Prohibitin has been hypothesized to act as a chaperone in aiding the assembly of respiratory complexes---in particular CI \[[@bb0215]\]. Indeed, recent data indicates that the CIII~2~ + CIV supercomplex content decreases in the absence of prohibitin \[[@bb0220]\].

Finally, the ETC mobile carriers Q and C*c* co-migrate with supercomplexes in BN-PAGE analyses \[[@bb0135]\]. Strikingly, the absence of C*c* destabilizes CI and CIV \[[@bb0225]\].

3. Cytochrome *c*: An Efficient Electron Carrier between CIII and CIV {#s0015}
=====================================================================

C*c* is an essential metalloprotein for mitochondrial metabolism and homeostasis, playing a dual-purpose role in cell life and death \[[@bb0230], [@bb0235], [@bb0240]\]. Under homeostasis, C*c* acts as electron carrier within the respiratory chain in the mitochondria. Voltammetry assays and current crystal structures of CIII and CIV complexed with C*c* resolve only one C*c* molecule per monomer \[[@bb0245], [@bb0250], [@bb0255]\]. However, earlier reports had suggested the existence of additional binding sites in both CIII and CIV \[[@bb0260], [@bb0265], [@bb0270], [@bb0275], [@bb0280]\]. Multiphasic kinetics observed in early assays for the oxidation of reduced C*c* by CIV can be fitted to a model with just one catalytic site. Such a simple model includes alternative binding conformations of the transient complex, with some of them being unable to transfer electrons but affecting the ET rate at the catalytic site \[[@bb0265],[@bb0285]\]. Direct C*c*-C*c*O binding studies performed by gel filtration evidenced a 2:1 stoichiometry, in which C*c* bound at a first site with a low dissociation constant and at a second site with less affinity \[[@bb0245]\]. Non-ET conformations within the complex between CIII and C*c* were also evidenced by steady state kinetic analysis, and so a binding model with more than one molecule of C*c* per molecule of CIII was proposed to explain the observed multiphasic kinetics \[[@bb0290]\]. More recently, *in solution* nuclear magnetic resonance (NMR) and isothermal titration calorimetry (ITC) experiments have confirmed the presence of a secondary binding site on cytochrome *c*~1~ (C*c*~1~) for C*c,* with an affinity 10-fold lower than that of the principal binding site \[[@bb0295],[@bb0300]\]. The two C*c*-binding sites of C*c*~1~ in CIII were named *proximal* and *distal*, according to Brownian Dynamics (BD) calculations and NMR-driven docking computations ([Fig. 2](#f0010){ref-type="fig"}). In the *proximal* site, the heme groups of C*c* and C*c*~1~ lay near each other, allowing electron transfer. The interaction surface on C*c* involves a hydrophobic patch around the heme cleft surrounded by positively charged residues. Such binding surface configuration determines the correct orientation of C*c* towards the heme group of C*c*~1~ and is common to other ET complexes \[[@bb0305],[@bb0310]\]. However, the surface used by C*c* to bind the *distal* site of C*c*~1~ is less-well defined when compared with the *proximal* one, in agreement with its lower affinity. Furthermore, the *distal* site lies far from the heme pocket of C*c*~1~, meaning there is low compatibly at the secondary site for efficient electron transfer.Fig. 2Binding surfaces of cytochrome *c* on cytochrome *c*~1~. Brownian Dynamics calculations and NMR-driven docking computations accommodate three C*c* molecules in the soluble domain of cytochrome *c*~1~. In the middle panel, two C*c* molecules are located at the *distal* sites of cytochrome *c*~1~ (C*c*~D~ and C*c*~D'~), whereas one C*c* molecule is at the *proximal* site of cytochrome *c*~1~ (C*c*~P~). On *left* and *right* panels, C*c* molecules are rotated 180° to expose interaction areas, with the residues colored according to the Kyte and Doolittle (KD) hydrophobicity scale; basic residues are in blue and the heme group (HEC) is in orange. Pictures were created with the UCFS Chimera software using the PDB structures for CIV (5XTH) and C*c* (2N9I) \[[@bb0440]\].Fig. 2

Secondary binding sites may play multiple roles in ETCs, including photosynthetic ones. For instance, in eukaryotic Photosystem I \[[@bb0315]\], secondary binding sites assure fast replacement of electron donor molecules once an ET reaction takes place, and disabling them is lethal. In the context of supercomplexes, these additional *distal* sites at CIII and CIV could facilitate the channeling of electron carriers by building a 'restricted diffusion pathway' for C*c* molecules across the surface of the two mitochondrial respiratory complexes instead of carrying electrons by random diffusion across de intermembrane mitochondrial space ([Fig. 3](#f0015){ref-type="fig"}). This fractal diffusion pathway substantially increases the efficiency of the OxPhos process in respect to the bulk 3D search, and decreases the production of reactive oxygen species (ROS) \[[@bb0320],[@bb0325]\]. Indeed, restraining diffusion by weak interactions with membranes, cytoskeletal structures and DNA substantially lowers the time a molecule needs to reach its target \[[@bb0330]\]. Both effects---increasing turnover and restraining diffusion of mobile carriers between two membrane complexes---are clear advantages of secondary sites in ETCs.Fig. 3Cytochrome *c* molecules surfing between respiratory complexes. A) *Fluid* model of dimeric CIII (green) and dimeric CIV (purple) embedded in the mitochondrial membrane. Isolated CIV is classically a dimer, as inferred from X-ray crystal structures \[[@bb0435]\]. B) *Solid* model of dimeric CIII and monomeric CIV, as shown in the recent Cryo-EM structure for human respiratory supercomplex complex \[[@bb0130]\]. P and D respectively stand for *distal* and *proximal* C*c* binding sites on each complex. "Pool" denotes C*c* population within the bulk intermembrane space. Pictures were created with the UCFS Chimera software using the PDB structures for CIII, CIV (5XTH) and cytochrome *c* (2N9I) \[[@bb0440]\].Fig. 3

4. Functional Implications of Post-Translational Modifications of Cytochrome *c* {#s0020}
================================================================================

The ETC is tightly regulated by post-translational modifications (PTMs), widening the function of its components under homeostatic and stress conditions \[[@bb0335],[@bb0340]\]. Notably, the structure and activity of C*c* are controlled *in vivo* by phosphorylation of threonine 28, serine 47 and tyrosine 48 and 97 \[[@bb0345], [@bb0350], [@bb0355], [@bb0360], [@bb0365], [@bb0370], [@bb0375], [@bb0380], [@bb0385], [@bb0390], [@bb0395]\].

Because of the low yield of most phosphorylated C*c* species obtained from cell extracts and the specific C*c* kinase being unknown, phosphomimic C*c* variants are the best alternative approach to analyze the effect of C*c* phosphorylation \[[@bb0380],[@bb0400],[@bb0405]\]. Actually, an extensive study of the functional effect of phosphorylation is unfeasible with purified phosphorylated C*c* species, but can be performed in an equivalent way with phosphomimic mutants.

Traditionally, tyrosine phosphorylation has been mimicked by mutating tyrosine to glutamate/aspartate. However, it has recently been established that the substitution of tyrosine with the non-canonical amino acid *p*-carboxymethyl-L-phenylalanine (*p*CMF) better mirrors tyrosine phosphorylation. Notably, all mutants maintain the 2:1 stoichiometry (C*c*:C*c*~1~ and C*c*:CIV) found for the wild-type (WT) species. Nevertheless, whereas all tested phosphomimetic C*c* species show similar affinities for the *proximal site* at C*c*~1~ ([Table 1](#t0005){ref-type="table"}), binding at the *distal site* is substantially hindered by the additional negative charge of C*c* \[[@bb0375],[@bb0385]\]. The affinity of C*c* towards bovine CIV changes depending on the residue of C*c* that is phosphorylated ([Table 1](#t0005){ref-type="table"}) \[[@bb0325],[@bb0385]\].Table 1Effect of post-translational modifications on cytochrome *c* binding and activity assays.Table 1C*c* speciesAffinitytowards CIII[a](#tf0005){ref-type="table-fn"}Affinitytowards CIVC*c*O activityProximal siteDistal siteProximal siteDistal siteFluid[b](#tf0010){ref-type="table-fn"}Fluid[c](#tf0015){ref-type="table-fn"}Solid[d](#tf0020){ref-type="table-fn"}T28D \[[@bb0375]\]\~**↓**n.d.n.d.↑n.d.T28E \[[@bb0380]\]n.d.n.d.n.d.n.d.**↓↓**pT28 \[[@bb0380]\]n.d.n.d.n.d.n.d.**↓↓**n.d.S47D \[[@bb0375]\]\~\~n.d.n.d.↑n.d.Y48*p*CMF \[[@bb0385]\]\~**↓↓↓↓↓**↑↓pY48 \[[@bb0390]\]n.d.n.d.n.d.n.d.↓n.d.Y97*p*CMF \[[@bb0325]\]n.d.n.d.**↑↑↑↑↑↑**↑**↑↑**pY97 \[[@bb0350]\]n.d.n.d.n.d.n.d.**↓↓**n.d.[^2][^3][^4][^5][^6][^7]

As noted in the Introduction section, the formation of supercomplexes has been proposed to increase ET efficiency during OxPhos, thereby minimizing the generation of ROS. ROS are generally generated in complexes I and III, and can damage key components of cells \[[@bb0410],[@bb0415]\]. The OxPhos process has been determined by the ability of C*c* to shuttle electrons to CIV. When C*c* performs a three-dimensional search visiting the bulk of the intermembrane mitochondrial space, every well-described phosphorylation in C*c* enhances the cytochrome *c* oxidase (C*c*O) activity *in vitro*, in C*c* oxidation assays using commercial CIV from bovine or equine heart ([Table 1](#t0005){ref-type="table"}) \[[@bb0325],[@bb0375],[@bb0385]\]. Nevertheless, CIV isolated from bovine tissues under conditions preserving the phosphorylation status of C*c*O shows increased *K*~M~ values for phosphorylated C*c* species and T28E mutant in O~2~ consumption assays \[[@bb0350],[@bb0380],[@bb0390]\]. Thus, simultaneous phosphorylation of both heme-containing proteins, C*c* and C*c*O, could act synergistically in inhibiting C*c*O activity. This apparent discrepancy could mainly be ascribed to PTMs of C*c*O.

When C*c*O activity is measured in mitochondria from cells grown in medium promoting the CIII-CIV supercomplex assembly (as part of the *solid* model), the Y48*p*CMF mutation decreases the electron donor ability of C*c* towards C*c*O. In contrast, *in vitro* observations mimicking the *fluid* model enhance C*c* oxidation ([Table 1](#t0005){ref-type="table"}). In the context of the *fluid* model, the *proximal sites* for C*c* on CIII and CIV govern ET reactions. However, in the *solid* model, the *distal sites*, which are non-ET functional sites, become important in limiting the diffusion of C*c* molecules on the respiratory CIII-CIV supercomplex.

The balance between relative affinities towards the *proximal* and *distal* sites of CIII and CIV determines C*c* exchange rates, alike in photosynthetic membrane complexes \[[@bb0315]\]. Indeed, the higher affinity of reduced Y48*p*CMF C*c* towards the *proximal* site at CIII impairs its replacement by a new, oxidized C*c* molecule. Further, the channeling of C*c* molecules at the CIII-CIV ensemble would be disrupted by its weaker binding to the *distal* sites, altogether affecting steady-state, C*c*O-dependent oxidation rate of C*c* ([Table 1](#t0005){ref-type="table"}) \[[@bb0385]\]. On the other hand, in the assays with isolated CIV, a decrease in the binding affinities may inhibit C*c*O activity \[[@bb0390]\], although an increased turnover could yield the opposite under steady-state conditions \[[@bb0385]\] ([Table 1](#t0005){ref-type="table"}).

In addition, the higher affinity of Y97*p*CMF C*c* towards both the *proximal* and *distal* sites of CIV could facilitate the electron C*c*-C*c*O flow and the pathway of C*c* molecules on CIII-CIV supercomplexes \[[@bb0325]\]. Although Tyr97 in WT C*c* is far from the adduct interface \[[@bb0255],[@bb0420]\], its phosphorylation may affect long-range interactions, C*c* dynamics and/or its orientation within the complex.

To sum up, phosphorylation of C*c* regulates the physico-chemical properties---such as alkaline transition, redox potential, stability, affinity towards partners, among others---that are essential for shuttling electrons. This would enable the rapid adjustment of C*c* function to changing cellular conditions.

5. Concluding Remarks {#s0025}
=====================

According to the data herein reviewed, C*c* plays a major regulatory role in OxPhos owing to its highly dynamic interactions with redox targets, and displays a fast turnover during the electron exchange cycle. Multiple binding sites in C*c* partners are essential to facilitate C*c* turnover and to define the diffusion pathway of the electron carrier. The effectiveness of such a constraint relies on the ability of cells to modulate both the intricate arrangements of ETC complexes into higher-order assemblies and the ample set of PTMs on C*c* and other ETC components. Whereas PTMs of CI, CIII and CIV could regulate their organization into supercomplexes, PTMs of C*c* could control the binding mode and affinity between the hemeprotein and its partners (CIII and CIV). In this context, the 'restricted diffusion pathway' of C*c* molecules between CIII and CIV could generate a large encounter ensemble of C*c* on the surface of ETC complexes previously assembled in supercomplexes, in which the hemeprotein would adopt several orientations in equilibrium with stereospecific positioning. In addition, the extra regulation layer of OxPhos activity by post-translational phosphorylation of C*c* could be essential to control oxygen consumption and the generation of harmful reactive species during homeostasis and pathology. C*c*---either phosphorylated or not---might play additional roles in aiding the assembly of ETC membrane complexes or even supercomplexes. Actually, the lack of C*c* disrupts the stability/assembly of CIV in yeasts, mammals and plants \[[@bb0225],[@bb0425],[@bb0430]\] and the hemeprotein migrates with CIII and CIV in BN-PAGE assays \[[@bb0135]\].

Conflict of Interests {#s0030}
=====================

All authors declare no conflict of interest.

This mini-review article is written *in memoriam* of Prof. Abel Schejter (1930-2017), who pioneered research studies on cytochrome *c* at Tel Aviv University. The work by the authors was supported by the Spanish Ministry of Economy and Competitiveness (BFU2015-71017/BMC MINECO/FEDER and PGC2018-096049-B-I00 BIO/BMC MICINN/FEDER, EU), Ramón Areces Foundation, European Social Fund, Andalusian Government (BIO-198) and TA Instruments. G.P.-M. was awarded a PhD fellowship from the Spanish Ministry of Education, Culture and Sport (FPU17/04604). Molecular graphics and analyses were performed using the UCSF Chimera software, developed by the Resource for Biocomputing, Visualization and Informatics at the University of California, San Francisco, with support from NIH P41-GM103311.

[^1]: These authors contributed equally to the manuscript.

[^2]: n.d.: not determined.

[^3]: 'Fluid' and 'Solid' refer to the two proposed models in which ETC are organised in the inner mitochondrial membrane.

[^4]: Affinity determined with the soluble N-terminal domain of *Arabidopsis thaliana* cytochrome *c*~1~.

[^5]: Activity measured as C*c* oxidation by CIV isolated from bovine or equine heart.

[^6]: Activity measured as O~2~ consumption by CIV isolated from bovine tissues under conditions preserving the enzyme phosphorylation status.

[^7]: Activity measured as C*c* oxidation in isolated yeast mitochondria.
